Cross Reference Logo
Citations to this article as recorded by CrossRef and RSC Journals (32 citations).

Synthetic mRNA cap analogs with a modified triphosphate bridge – synthesis, applications and prospects
Jacek Jemielity, Joanna Kowalska, Anna Maria Rydzik and Edward Darzynkiewicz
New J. Chem., 2010, 34, 829
DOI: 10.1039/c0nj00041h

Biomaterials for mRNA delivery
Mohammad Ariful Islam, Emma K. G. Reesor, Yingjie Xu, Harshal R. Zope, Bruce R. Zetter and Jinjun Shi
Biomater. Sci., 2015, 3, 1519
DOI: 10.1039/C5BM00198F

Nucleic acid degradation as barrier to gene delivery: a guide to understand and overcome nuclease activity
Heyang Zhang, Jo Vandesompele, Kevin Braeckmans, Stefaan C. De Smedt and Katrien Remaut
Chem. Soc. Rev., 2024, 53, 317
DOI: 10.1039/D3CS00194F

How To Form a Phosphate Anhydride Linkage in Nucleotide Derivatives
Yuliya V. Sherstyuk and Tatyana V. Abramova
ChemBioChem, 2015, 16, 2562
DOI: 10.1002/cbic.201500406

Versatile strategy using vaccinia virus-capping enzyme to synthesize functional 5′ cap-modified mRNAs
Hirohisa Ohno, Sae Akamine, Megumi Mochizuki, Karin Hayashi, Shinichiro Akichika, Tsutomu Suzuki and Hirohide Saito
Nucleic Acids Research, 2023, 51, e34
DOI: 10.1093/nar/gkad019

mRNA as gene therapeutic: How to control protein expression
Geertrui Tavernier, Oliwia Andries, Jo Demeester, Niek N. Sanders, Stefaan C. De Smedt and Joanna Rejman
Journal of Controlled Release, 2011, 150, 238
DOI: 10.1016/j.jconrel.2010.10.020

Synthesis, properties, and biological activity of boranophosphate analogs of the mRNA cap: versatile tools for manipulation of therapeutically relevant cap-dependent processes
Joanna Kowalska, Anna Wypijewska del Nogal, Zbigniew M. Darzynkiewicz, Janina Buck, Corina Nicola, Andreas N. Kuhn, Maciej Lukaszewicz, Joanna Zuberek, Malwina Strenkowska, Marcin Ziemniak, Maciej Maciejczyk, Elzbieta Bojarska, Robert E. Rhoads, Edward Darzynkiewicz, Ugur Sahin and Jacek Jemielity
Nucleic Acids Research, 2014, 42, 10245
DOI: 10.1093/nar/gku757

An overview of rational design of mRNA-based therapeutics and vaccines
Kenneth K.W. To and William C.S. Cho
Expert Opinion on Drug Discovery, 2021, 16, 1307
DOI: 10.1080/17460441.2021.1935859

mRNA-based therapeutics: looking beyond COVID-19 vaccines
Hamideh Parhiz, Elena N Atochina-Vasserman and Drew Weissman
The Lancet, 2024, 403, 1192
DOI: 10.1016/S0140-6736(23)02444-3

The legacy of mRNA engineering: A lineup of pioneers for the Nobel Prize
Miroslaw Janowski and Anna Andrzejewska
Molecular Therapy - Nucleic Acids, 2022, 29, 272
DOI: 10.1016/j.omtn.2022.07.003

mRNA medicine: Recent progresses in chemical modification, design, and engineering
Xiaowen Hou, Jinjun Shi and Yuling Xiao
Nano Res., 2024, 17, 9015
DOI: 10.1007/s12274-024-6978-6

The potential of N2-modified cap analogues for precise genetic manipulation through mRNA engineering
Karol Kurpiejewski, Anna Stankiewicz-Drogon, Karolina Piecyk, Eliza Rajkowska, Paulina Skrzypczyk, Jingping Geng, Edward Darzynkiewicz, Renata Grzela and Marzena Jankowska-Anyszka
Front. Mol. Biosci., 2024, 10
DOI: 10.3389/fmolb.2023.1269028

Cap analogs modified with 1,2-dithiodiphosphate moiety protect mRNA from decapping and enhance its translational potential
Malwina Strenkowska, Renata Grzela, Maciej Majewski, Katarzyna Wnek, Joanna Kowalska, Maciej Lukaszewicz, Joanna Zuberek, Edward Darzynkiewicz, Andreas N. Kuhn, Ugur Sahin and Jacek Jemielity
Nucleic Acids Res, 2016, gkw896
DOI: 10.1093/nar/gkw896

mRNA therapeutics deliver a hopeful message
Zifu Zhong, Séan Mc Cafferty, Francis Combes, Hanne Huysmans, Joyca De Temmerman, Arlieke Gitsels, Daisy Vanrompay, João Portela Catani and Niek N. Sanders
Nano Today, 2018, 23, 16
DOI: 10.1016/j.nantod.2018.10.005

Chemically Modified mocRNAs for Highly Efficient Protein Expression in Mammalian Cells
Abhishek Aditham, Hailing Shi, Jianting Guo, Hu Zeng, Yiming Zhou, Sarah Dunn Wade, Jiahao Huang, Jia Liu and Xiao Wang
ACS Chem. Biol., 2022, 17, 3352
DOI: 10.1021/acschembio.1c00569

mRNA-Vaccine Platform: Features of Obtaining and Delivery of mRNA
V. R. Litvinova, A. P. Rudometov, L. I. Karpenko and A. A. Ilyichev
RUBI, 2023, 49, 134
DOI: 10.31857/S013234232302015X

Development of mRNA vaccines and their prophylactic and therapeutic applications
Kyuri Lee, Minjeong Kim, Yunmi Seo and Hyukjin Lee
Nano Res., 2018, 11, 5173
DOI: 10.1007/s12274-018-2095-8

mRNA Vaccine Platform: mRNA Production and Delivery
V. R. Litvinova, A. P. Rudometov, L. I. Karpenko and A. A. Ilyichev
Russ J Bioorg Chem, 2023, 49, 220
DOI: 10.1134/S1068162023020152

Selection of UTRs in mRNA-Based Gene Therapy and Vaccines
Ilya A. Volkhin, Anastasia Iu. Paremskaia, Maria A. Dashian, Darya S. Smeshnova, Roman E. Pavlov, Olga N. Mityaeva, Pavel Yu. Volchkov and Andrei A. Deviatkin
Biochemistry Moscow, 2025, 90, 725
DOI: 10.1134/S0006297924604659

Potential Therapeutic Applications of Rna Cap Analogs
Marcin Ziemniak, Malwina Strenkowska, Joanna Kowalska and Jacek Jemielity
Future Med. Chem., 2013, 5, 1141
DOI: 10.4155/fmc.13.96

Synthetic modified messenger RNA for therapeutic applications
Minsong Gao, Qingyi Zhang, Xin-Hua Feng and Jianzhao Liu
Acta Biomaterialia, 2021, 131, 1
DOI: 10.1016/j.actbio.2021.06.020

Modified mRNA as an alternative to plasmid DNA (pDNA) for transcript replacement and vaccination therapy
Hyewon Youn and June-Key Chung
Expert Opinion on Biological Therapy, 2015, 15, 1337
DOI: 10.1517/14712598.2015.1057563

Emergence of synthetic mRNA: In vitro synthesis of mRNA and its applications in regenerative medicine
Hyokyoung Kwon, Minjeong Kim, Yunmi Seo, Yae Seul Moon, Hwa Jeong Lee, Kyuri Lee and Hyukjin Lee
Biomaterials, 2018, 156, 172
DOI: 10.1016/j.biomaterials.2017.11.034

Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyond
Britta Vallazza, Sebastian Petri, Marco A. Poleganov, Florian Eberle, Andreas N. Kuhn and Ugur Sahin
WIREs RNA, 2015, 6, 471
DOI: 10.1002/wrna.1288

RNA-based therapy for osteogenesis
Pinpin Wang, Federico Perche, Delphine Logeart-Avramoglou and Chantal Pichon
International Journal of Pharmaceutics, 2019, 569, 118594
DOI: 10.1016/j.ijpharm.2019.118594

Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives
Itziar Gómez-Aguado, Julen Rodríguez-Castejón, Mónica Vicente-Pascual, Alicia Rodríguez-Gascón, María Ángeles Solinís and Ana del Pozo-Rodríguez
Nanomaterials, 2020, 10, 364
DOI: 10.3390/nano10020364

Phosphate-modified analogues of m 7 GTP and m 7 Gppppm 7 G—Synthesis and biochemical properties
Marcin Ziemniak, Joanna Kowalska, Maciej Lukaszewicz, Joanna Zuberek, Katarzyna Wnek, Edward Darzynkiewicz and Jacek Jemielity
Bioorganic & Medicinal Chemistry, 2015, 23, 5369
DOI: 10.1016/j.bmc.2015.07.052

Amino-Functionalized 5′ Cap Analogs as Tools for Site-Specific Sequence-Independent Labeling of mRNA
Marcin Warminski, Pawel J. Sikorski, Zofia Warminska, Maciej Lukaszewicz, Anna Kropiwnicka, Joanna Zuberek, Edward Darzynkiewicz, Joanna Kowalska and Jacek Jemielity
Bioconjugate Chem., 2017, 28, 1978
DOI: 10.1021/acs.bioconjchem.7b00291

Design, Assembly, Production, and Transfection of Synthetic Modified mRNA
Sanders Oh and John A. Kessler
Methods, 2018, 133, 29
DOI: 10.1016/j.ymeth.2017.10.008

Synthesis and properties of mRNA cap analogs containing imidodiphosphate moiety—fairly mimicking natural cap structure, yet resistant to enzymatic hydrolysis
Anna M. Rydzik, Marta Kulis, Maciej Lukaszewicz, Joanna Kowalska, Joanna Zuberek, Zbigniew M. Darzynkiewicz, Edward Darzynkiewicz and Jacek Jemielity
Bioorganic & Medicinal Chemistry, 2012, 20, 1699
DOI: 10.1016/j.bmc.2012.01.013

Modified ARCA analogs providing enhanced translational properties of capped mRNAs
Ilona Kocmik, Karolina Piecyk, Magdalena Rudzinska, Anna Niedzwiecka, Edward Darzynkiewicz, Renata Grzela and Marzena Jankowska-Anyszka
Cell Cycle, 2018, 17, 1624
DOI: 10.1080/15384101.2018.1486164

Development of a Thiophosphorylation Process for the Synthesis of 2′F-Thio-Adenosine Monophosphate
Jennifer V. Obligacion, Tao Wang, Thomas T. Kwok, Daniel Zewge, Ryan D. Cohen, Mikhail Reibarkh, Artis Klapars, Kerstin Zawatzky, Stephanus Axnanda, Zhu Liu, Zachary E. X. Dance, Joseph P. Smith, Wendy Zhong, Heather Wang, Cheol K. Chung, Nastaran Salehi Marzijarani and Zhijian Liu
Org. Process Res. Dev., 2024, 28, 588
DOI: 10.1021/acs.oprd.3c00429